The current treatment algorithm for chronic thromboembolic pulmonary hypertension (CTEPH) as depicted in the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines on the diagnosis and treatment of pulmonary hypertension (PH) includes a multimodal approach of combinations of pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA) and medical therapies to target major vessel pulmonary vascular lesions, and microvasculopathy. Today, BPA of >1700 patients has been reported in the literature from centers in Asia, the US, and also Europe; many more patients have been treated outside literature reports. As BPA becomes part of routine care of patients with CTEPH, benchmarks for safe and effective care delivery become increasingly important. In light of this development, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function has decided to publish a document that helps standardize BPA to meet the need of uniformity in patient selection, procedural planning, technical approach, materials and devices, treatment goals, complications including their management, and patient follow-up, thus complementing the guidelines. Delphi methodology was utilized for statements that were not evidence based. First, an anatomical nomenclature and a description of vascular lesions are provided. Second, treatment goals and definitions of complete BPA are outlined. Third, definitions of complications are presented which may be the basis for a standardized reporting in studies involving BPA. The document is intended to serve as a companion to the official ESC/ERS guidelines.

Aarhus University Hospital Palle Juul Jensens Boulevard 99 8200 Aarhus NDenmark

Cardiology Department Grenoble Alpes University Hospital 38043 Grenoble France

Department of Cardiology Bern University Hospital Inselspital University of Bern Freiburgstrasse 18 3010 Bern Switzerland

Department of Cardiology National Hospital Organization Okayama Medical Center 1711 1 Tamasu Kita ku Okayama 701 1192 Japan

Department of Cardiology Oslo University Hospital Rikshospitalet Pb 4950 Nydalen 0424 Oslo Norway

Department of Cardiology St Antonius Hospital Koekoekslaan 1 3435 CM Nieuwegein The Netherlands

Department of Cardiology University Medical Center Utrecht Heidelberglaan 100 3584 CX Utrecht The Netherlands

Department of Internal Medicine 2 Cardiology and Comprehensive Center of Cardiovascular Medicine CCVM Medical University of Vienna Währinger Gürtel 18 20 Vienna A 1090 Austria

Department of Internal Medicine and Cardiology Medical University of Warsaw Zwirki 1 Wigury 61 02 091 Warsaw Poland

Department of Pulmonary Circulation Thromboembolic Diseases and Cardiology Centre of Postgraduate Medical Education EHC Otwock Borowa 14 18 Otwock 05 400 Poland

Department of Thoracic Surgery Kerckhoff Heart and Thorax Centre Benekestrasse 2 8 61231 Bad Nauheim Germany

Dept of Cardiology and Cologne Cardiovascular Research Center Heart Center at the University Hospital Cologne Kerpener Str 62 50937 Köln Germany

Dipartimento DIMEC Università di Bologna 40126 Bologna Italy

General University Hospital U Nemocnice 2 128 08 Prague 2 Czech Republic

Hospital Universitario 12 de octubre Avda de Cordoba SN 28041 Madrid Spain

Interventional Radiology Department Marie Lannelongue Hospital Le Plessis Robinson 92350France

Medizinische Hochschule Hannover Institut für Diagnostische und Interventionelle Radiologie Carl Neuberg Str 1 30625 Hannover

Pulmonary Circulation Centre Jagiellonian University Medical College John Paul 2 Hospital in Krakow Pradnicka Str 80 31 202 Krakow

Royal Free Hospital London Pond Street Middlesex London NW3 2QG

See more in PubMed

Kennedy  MK, Kennedy  SA, Tan  KT, de Perrot  M, Bassett  P, McInnis  MC, et al.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. Cardiovasc Intervent Radiol  2023;46:5–18. 10.1007/s00270-022-03323-8 PubMed DOI

Kawakami  T, Matsubara  H, Shinke  T, Abe  K, Kohsaka  S, Hosokawa  K, et al.  Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial. Lancet Respir Med  2022;10:949–960. 10.1016/S2213-2600(22)00171-0 PubMed DOI

Jaïs  X, Brenot  P, Bouvaist  H, Jevnikar  M, Canuet  M, Chabanne  C, et al.  Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. Lancet Respir Med  2022;10:961–971. 10.1016/S2213-2600(22)00214-4 PubMed DOI

Humbert  M, Kovacs  G, Hoeper  MM, Badagliacca  R, Berger  RMF, Brida  M, et al.  2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J  2022;43:3618–3731. 10.1093/eurheartj/ehac237 PubMed DOI

Fukuda  K, Date  H, Doi  S, Fukumoto  Y, Fukushima  N, Hatano  M, et al.  Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017). Circ J  2019;83:842–945. 10.1253/circj.CJ-66-0158 PubMed DOI

Kataoka  M, Inami  T, Hayashida  K, Shimura  N, Ishiguro  H, Abe  T, et al.  Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv  2012;5:756–762. 10.1161/CIRCINTERVENTIONS.112.971390 PubMed DOI

Mizoguchi  H, Ogawa  A, Munemasa  M, Mikouchi  H, Ito  H, Matsubara  H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv  2012;5:748–755. 10.1161/CIRCINTERVENTIONS.112.971077 PubMed DOI

Sugimura  K, Fukumoto  Y, Satoh  K, Nochioka  K, Miura  Y, Aoki  T, et al.  Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J  2012;76:485–488. 10.1253/circj.CJ-11-1217 PubMed DOI

Shimura  N, Kataoka  M, Inami  T, Yanagisawa  R, Ishiguro  H, Kawakami  T, et al.  Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol  2015;183:138–142. 10.1016/j.ijcard.2015.01.034 PubMed DOI

Yanaka  K, Nakayama  K, Shinke  T, Shinkura  Y, Taniguchi  Y, Kinutani  H, et al.  Sequential hybrid therapy with pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. J Am Heart Assoc  2018;7:e008838. 10.1161/JAHA.118.008838 PubMed DOI PMC

Araszkiewicz  A, Darocha  S, Pietrasik  A, Pietura  R, Jankiewicz  S, Banaszkiewicz  M, et al.  Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol  2019;278:232–237. 10.1016/j.ijcard.2018.10.066 PubMed DOI

Poch  DS, Mahmud  E, Patel  M, Papamatheakis  D, Fernandes  T, Kerr  K, et al.  Patient selection for balloon pulmonary angioplasty: six-year results from a high volume PTE surgical center. Pulm Circ  2022;12:e12148. 10.1002/pul2.12148 PubMed DOI PMC

Siennicka  A, Darocha  S, Banaszkiewicz  M, Kędzierski  P, Dobosiewicz  A, Błaszczak  P, et al.  Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team. Ther Adv Respir Dis  2019;13:1753466619891529. 10.1177/1753466619891529 PubMed DOI PMC

Taniguchi  Y, Jaïs  X, Jevnikar  M, Boucly  A, Weatherald  J, Brenot  P, et al.  Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant  2019;38:833–842. 10.1016/j.healun.2019.04.006 PubMed DOI

Miwa  H, Tanabe  N, Jujo  T, Kato  F, Anazawa  R, Yamamoto  K, et al.  Long-Term outcome of chronic thromboembolic pulmonary hypertension at a single Japanese pulmonary endarterectomy center. Circ J  2018;82:1428–1436. 10.1253/circj.CJ-17-1242 PubMed DOI

Humbert  M, Galié  N, Meszaros  G. Competency requirements for ERN-lung PH centres. 2021. https://ern-lung.eu/inhalt/wp-content/uploads/2020/10/PH-MCC.pdf.

Voorburg  JA, Cats  VM, Buis  B, Bruschke  AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest  1988;94:1249–1253. 10.1378/chest.94.6.1249 PubMed DOI

Feinstein  JA, Goldhaber  SZ, Lock  JE, Ferndandes  SM, Landzberg  MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation  2001;103:10–13. 10.1161/01.CIR.103.1.10 PubMed DOI

Wiedenroth  CB, Liebetrau  C, Breithecker  A, Guth  S, Lautze  HJ, Ortmann  E, et al.  Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant  2016;35:591–596. 10.1016/j.healun.2015.10.030 PubMed DOI

NOMENCLATURE Of broncho-pulmonary anatomy; an international nomenclature accepted by the thoracic society. Thorax  1950;5:222–228. 10.1136/thx.5.3.222 PubMed DOI PMC

Kandathil  A, Chamarthy  M. Pulmonary vascular anatomy & anatomical variants. Cardiovasc Diagn Ther  2018;8:201–207. 10.21037/cdt.2018.01.04 PubMed DOI PMC

Shimokawahara  H, Ogawa  A, Mizoguchi  H, Yagi  H, Ikemiyagi  H, Matsubara  H. Vessel stretching is a cause of lumen enlargement immediately after balloon pulmonary angioplasty: intravascular ultrasound analysis in patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv  2018;11:e006010. 10.1161/CIRCINTERVENTIONS.117.006010 PubMed DOI

Räber  L, Ueki  Y, Lang  IM. Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. EuroIntervention  2019;15:e814–e815. 10.4244/EIJ-D-18-01212 PubMed DOI

Jansa  P, Ambrož  D, Aschermann  M, Černý  V, Dytrych  V, Heller  S, et al.  Hospitalisation is prognostic of survival in chronic thromboembolic pulmonary hypertension. J Clin Med  2022;11:6189. 10.3390/jcm11206189 PubMed DOI PMC

Brenot  P, Jais  X, Taniguchi  Y, Garcia Alonso  C, Gerardin  B, Mussot  S, et al.  French Experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J  2019;53:1802095. 10.1183/13993003.02095-2018 PubMed DOI PMC

Martínez-Santos  P, Velázquez-Martín  MT, Barberá  JA, Fernández Pérez  C, López-Meseguer  M, López-Reyes  R, et al.  Chronic thromboembolic pulmonary hypertension in Spain: a decade of change. Rev Esp Cardiol (Engl Ed)  2021;74:384–392. 10.1016/j.rec.2020.06.006 PubMed DOI

Neumann  F-J, Sousa-Uva  M, Ahlsson  A, Alfonso  F, Banning  AP, Benedetto  U, et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J  2018;40:87–165. 10.1093/eurheartj/ehy394 DOI

Bednarczuk  T, Brix  TH, Schima  W, Zettinig  G, Kahaly  GJ. 2021 European Thyroid Association guidelines for the management of iodine-based contrast media-induced thyroid dysfunction. Eur Thyroid J  2021;10:269–284. 10.1159/000517175 PubMed DOI PMC

Quadery  SR, Swift  AJ, Billings  CG, Thompson  AAR, Elliot  CA, Hurdman  J, et al.  The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. Eur Respir J  2018;52:1800589. 10.1183/13993003.00589-2018 PubMed DOI PMC

Darocha  S, Araszkiewicz  A, Kurzyna  M, Banaszkiewicz  M, Jankiewicz  S, Dobosiewicz  A, et al.  Balloon pulmonary angioplasty in technically operable and technically inoperable chronic thromboembolic pulmonary hypertension. J Clin Med  2021;10:1038. 10.3390/jcm10051038 PubMed DOI PMC

Nishihara  T, Shimokawahara  H, Ogawa  A, Naito  T, Une  D, Mukai  T, et al.  Comparison of the safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with surgically accessible and inaccessible lesions. J Heart Lung Transplant  2023;42:786–794. 10.1016/j.healun.2023.01.003 PubMed DOI

Barco  S, Klok  FA, Konstantinides  SV, Dartevelle  P, Fadel  E, Jenkins  D, et al.  Sex-specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH Registry. J Thromb Haemost  2020;18:151–161. 10.1111/jth.14629 PubMed DOI

Cruz-Utrilla  A, Cristo-Ropero  MJ, Calderón-Flores  M, Velázquez  M, López-Gude  MJ, Revilla Ostolaza  Y, et al.  Sex differences in chronic thromboembolic pulmonary hypertension. Treatment options over time in a national referral center. J Clin Med  2021;10:4251. 10.3390/jcm10184251 PubMed DOI PMC

Kerr  KM, Elliott  CG, Chin  K, Benza  RL, Channick  RN, Davis  RD, et al.  Results from the United States Chronic Thromboembolic Pulmonary Hypertension Registry: enrollment characteristics and 1-year follow-up. Chest  2021;160:1822–1831. 10.1016/j.chest.2021.05.052 PubMed DOI PMC

Shigeta  A, Tanabe  N, Shimizu  H, Hoshino  S, Maruoka  M, Sakao  S, et al.  Gender differences in chronic thromboembolic pulmonary hypertension in Japan. Circ J  2008;72:2069–2074. 10.1253/circj.CJ-08-0377 PubMed DOI

Guth  S, D'Armini  AM, Delcroix  M, Nakayama  K, Fadel  E, Hoole  SP, et al.  Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry. ERJ Open Res  2021;7:00850-2020. 10.1183/23120541.00850-2020 PubMed DOI PMC

Velázquez  MM, Maneiro Melón  N, Albarrán González-Trevilla  A, Sarnago Cebada  F, Huertas Nieto  S, Cruz-Utrilla  A, et al.  Balloon pulmonary angioplasty can be an effective and safe therapeutic option in non-surgical elderly patients. Front Cardiovasc Med  2022;9:1001518. 10.3389/fcvm.2022.1001518 PubMed DOI PMC

Ikeda  N, Iijima  R, Hara  H, Hiroi  Y, Nakamura  M. Preprocedural frailty is strongly associated with symptoms after balloon pulmonary angioplasty. Glob Health Med  2022;4:45–51. 10.35772/ghm.2021.01019 PubMed DOI PMC

Roik  M, Wretowski  D, Łabyk  A, Irzyk  K, Lichodziejewska  B, Dzikowska-Diduch  O, et al.  Refined balloon pulmonary angioplasty-A therapeutic option in very elderly patients with chronic thromboembolic pulmonary hypertension. J Interv Cardiol  2017;30:249–255. 10.1111/joic.12387 PubMed DOI

Yamagata  Y, Ikeda  S, Nakata  T, Yonekura  T, Koga  S, Muroya  T, et al.  Balloon pulmonary angioplasty is effective for treating peripheral-type chronic thromboembolic pulmonary hypertension in elderly patients. Geriatr Gerontol Int  2018;18:678–684. 10.1111/ggi.13224 PubMed DOI

Roik  M, Wretowski  D, Labyk  A, Kostrubiec  M, Irzyk  K, Dzikowska-Diduch  O, et al.  Refined balloon pulmonary angioplasty driven by combined assessment of intra-arterial anatomy and physiology–multimodal approach to treated lesions in patients with non-operable distal chronic thromboembolic pulmonary hypertension–technique, safety and efficacy of 50 consecutive angioplasties. Int J Cardiol  2016;203:228–235. 10.1016/j.ijcard.2015.10.116 PubMed DOI

Roik  M, Wretowski  D, Kostrubiec  M, Dzikowska-Diduch  O, Łabyk  A, Irzyk  K, et al.  High prevalence of severe coronary artery disease in elderly patients with non-operable chronic thromboembolic pulmonary hypertension referred for balloon pulmonary angioplasty. Postepy Kardiol Interwencyjnej  2016;12:355–359. 10.5114/aic.2016.63637 PubMed DOI PMC

Hinrichs  JB, von Falck  C, Hoeper  MM, Olsson  KM, Wacker  FK, Meyer  BC, et al.  Pulmonary artery imaging in patients with chronic thromboembolic pulmonary hypertension: comparison of cone-beam CT and 64-row multidetector CT. J Vasc Interv Radiol  2016;27:361–368. 10.1016/j.jvir.2015.11.046 PubMed DOI

Ang  L, McDivit Mizzell  A, Daniels  LB, Ben-Yehuda  O, Mahmud  E. Optimal technique for performing invasive pulmonary angiography for chronic thromboembolic pulmonary disease. J Invasive Cardiol  2019;31:E211–e219. PubMed

Gerges  C, Friewald  R, Gerges  M, Shafran  I, Sadushi-Koliçi  R, Skoro-Sajer  N, et al.  Efficacy and safety of percutaneous pulmonary artery subtotal occlusion and chronic total occlusion intervention in chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv  2021;14:e010243. 10.1161/CIRCINTERVENTIONS.120.010243 PubMed DOI

Gerges  C, Gerges  M, Friewald  R, Fesler  P, Dorfmuller  P, Sharma  S, et al.  Microvascular disease in chronic thromboembolic pulmonary hypertension: hemodynamic phenotyping and histomorphometric assessment. Circulation  2020;141:376–386. 10.1161/CIRCULATIONAHA.119.041515 PubMed DOI

Cannon  JE, Su  L, Kiely  DG, Page  K, Toshner  M, Swietlik  E, et al.  Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation  2016;133:1761–1771. 10.1161/CIRCULATIONAHA.115.019470 PubMed DOI PMC

Delcroix  M, Lang  I, Pepke-Zaba  J, Jansa  P, D'Armini  AM, Snijder  R, et al.  Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation  2016;133:859–871. 10.1161/CIRCULATIONAHA.115.016522 PubMed DOI

Palazzini  M, Saia  F, Taglieri  N, Guarino  D, Rotunno  M, Galiѐ  N, et al.  Balloon pulmonary angioplasty after pulmonary thromboendarterectomy. Ann Cardiothorac Surg  2022;11:192–194. 10.21037/acs-2021-pte-19 PubMed DOI PMC

Andersen  A, Hansen  JV, Dragsbaek  SJ, Maeng  M, Andersen  MJ, Andersen  G, et al.  Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy. Pulm Circ  2022;12:e12115. 10.1002/pul2.12115 PubMed DOI PMC

Ito  R, Yamashita  J, Sasaki  Y, Ikeda  S, Suzuki  S, Murata  N, et al.  Efficacy and safety of balloon pulmonary angioplasty for residual pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol  2021;334:105–109. 10.1016/j.ijcard.2021.04.013 PubMed DOI

Coghlan  JG. Balloon pulmonary angioplasty: does it have a role in CTED?  Pulm Circ  2018;8:2045893218754887. 10.1177/2045893218754887 PubMed DOI PMC

Wiedenroth  CB, Ghofrani  HA, Adameit  MSD, Breithecker  A, Haas  M, Kriechbaum  S, et al.  Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. Pulm Circ  2018;8:2045894018783996. 10.1177/2045894018783996 PubMed DOI PMC

Inami  T, Kataoka  M, Kikuchi  H, Goda  A, Satoh  T. Balloon pulmonary angioplasty for symptomatic chronic thromboembolic disease without pulmonary hypertension at rest. Int J Cardiol  2019;289:116–118. 10.1016/j.ijcard.2019.04.080 PubMed DOI

Held  M, Kolb  P, Grün  M, Jany  B, Hübner  G, Grgic  A, et al.  Functional characterization of patients with chronic thromboembolic disease. Respiration  2016;91:503–509. 10.1159/000447247 PubMed DOI

Humbert  M, Simonneau  G, Pittrow  D, Delcroix  M, Pepke-Zaba  J, Langleben  D, et al.  Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant  2022;41:716–721. 10.1016/j.healun.2022.02.002 PubMed DOI

Douketis  JD, Spyropoulos  AC, Kaatz  S, Becker  RC, Caprini  JA, Dunn  AS, et al.  Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med  2015;373:823–833. 10.1056/NEJMoa1501035 PubMed DOI PMC

Kataoka  M, Inami  T, Kawakami  T, Fukuda  K, Satoh  T. Balloon pulmonary angioplasty (percutaneous transluminal pulmonary angioplasty) for chronic thromboembolic pulmonary hypertension: a Japanese perspective. JACC Cardiovasc Interv  2019;12:1382–1388. 10.1016/j.jcin.2019.01.237 PubMed DOI

Coghlan  JG, Rothman  AM, Hoole  SP. Balloon pulmonary angioplasty: state of the art. Interv Cardiol  2020;16:e02. 10.15420/icr.2020.14 PubMed DOI PMC

Shinkura  Y, Nakayama  K, Yanaka  K, Kinutani  H, Tamada  N, Tsuboi  Y, et al.  Extensive revascularisation by balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension beyond haemodynamic normalisation. EuroIntervention  2018;13:2060–2068. 10.4244/EIJ-D-17-00157 PubMed DOI

Riedel  M, Stanek  V, Widimsky  J, Prerovsky  I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest  1982;81:151–158. 10.1378/chest.81.2.151 PubMed DOI

Shigetoshi  M, Hatanaka  K, Ogawa  A, Tabuchi  I, Shimokawahara  H, Munemasa  M, et al.  Oxygen inhalation can selectively dilate pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension before balloon angioplasty. J Cardiol  2022;79:265–269. 10.1016/j.jjcc.2021.09.003 PubMed DOI

Darocha  S, Pietura  R, Banaszkiewicz  M, Pietrasik  A, Kownacki  Ł, Torbicki  A, et al.  Balloon pulmonary angioplasty with stent implantation as a treatment of proximal chronic thromboembolic pulmonary hypertension. Diagnostics (Basel)  2020;10:363. 10.3390/diagnostics10060363 PubMed DOI PMC

Cao  Y, Singh  V, Jiang  N, Wei  R, Jiang  K, Wang  H. Stenting for pulmonary artery stenosis resistant to balloon pulmonary angioplasty in chronic thrombo-embolic pulmonary hypertension: a bail out strategy. Eur Heart J Case Rep  2021;5:ytab071. 10.1093/ehjcr/ytab071 PubMed DOI PMC

Inami  T, Kataoka  M, Shimura  N, Ishiguro  H, Yanagisawa  R, Fukuda  K, et al.  Pressure-wire-guided percutaneous transluminal pulmonary angioplasty: a breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension. JACC Cardiovasc Interv  2014;7:1297–1306. 10.1016/j.jcin.2014.06.010 PubMed DOI

Panda  A, Bhalla  AS, Goyal  A. Bronchial artery embolization in hemoptysis: a systematic review. Diagn Interv Radiol  2017;23:307–317. 10.5152/dir.2017.16454 PubMed DOI PMC

Chiu  TM, Chu  SY. Hypersensitivity reactions to iodinated contrast Media. Biomedicines  2022;10:1036. 10.3390/biomedicines10051036 PubMed DOI PMC

Lameire  NH, Levin  A, Kellum  JA, Cheung  M, Jadoul  M, Winkelmayer  WC, et al.  Harmonizing acute and chronic kidney disease definition and classification: report of a kidney disease: improving global outcomes (KDIGO) consensus conference. Kidney Int  2021;100:516–526. 10.1016/j.kint.2021.06.028 PubMed DOI

Nef  HM, Achenbach  S, Birkemeyer  R, Bufe  A, Dörr  O, Elsässer  A, et al.  Manual der arbeitsgruppe interventionelle kardiologie (AGIK) der deutschen gesellschaft für kardiologie—herz- und kreislaufforschung e. V. (DGK). Der Kardiologe Volume  2021;15:542–584. 10.1007/s12181-021-00504-6 DOI

Ejiri  K, Ogawa  A, Fujii  S, Ito  H, Matsubara  H. Vascular injury is a Major cause of lung injury after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv  2018;11:e005884. 10.1161/CIRCINTERVENTIONS.117.005884 PubMed DOI

Wiedenroth  CB, Deissner  H, Adameit  MSD, Kriechbaum  SD, Ghofrani  HA, Breithecker  A, et al.  Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: impact on the outcome. J Heart Lung Transplant  2022;41:1086–1094. 10.1016/j.healun.2022.05.002 PubMed DOI

Minatsuki  S, Takahara  M, Kiyosue  A, Kodera  S, Hatano  M, Ando  J, et al.  Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry. Open Heart  2021;8:e001721. 10.1136/openhrt-2021-001721 PubMed DOI PMC

Kim  NH, Delcroix  M, Jais  X, Madani  MM, Matsubara  H, Mayer  E, et al.  Chronic thromboembolic pulmonary hypertension. Eur Respir J  2019;53:1801915. 10.1183/13993003.01915-2018 PubMed DOI PMC

Ikeda  N, Kubota  S, Okazaki  T, Iijima  R, Hara  H, Hiroi  Y, et al.  The predictors of complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Catheter Cardiovasc Interv  2019;93:E349–E356. 10.1002/ccd.28133 PubMed DOI

Kawakami  T, Ogawa  A, Miyaji  K, Mizoguchi  H, Shimokawahara  H, Naito  T, et al.  Novel angiographic classification of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty. Circ Cardiovasc Interv  2016;9:e003318. 10.1161/CIRCINTERVENTIONS.115.003318 PubMed DOI

Stępniewski  J, Magoń  W, Waligóra  M, Jonas  K, Bochenek  M, Przybylski  R, et al.  Hemodynamic effects of balloon pulmonary angioplasty for the treatment of total and subtotal pulmonary artery occlusions in inoperable chronic thromboembolic pulmonary hypertension. Int J Cardiol  2022;361:71–76. 10.1016/j.ijcard.2022.05.029 PubMed DOI

Inami  T, Kataoka  M, Shimura  N, Ishiguro  H, Yanagisawa  R, Taguchi  H, et al.  Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv  2013;6:725–736. 10.1016/j.jcin.2013.03.009 PubMed DOI

Darocha  S, Banaszkiewicz  M, Pietrasik  A, Siennicka  A, Piorunek  M, Grochowska  E, et al.  Changes in estimated glomerular filtration after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Cardiorenal Med  2020;10:22–31. 10.1159/000502254 PubMed DOI

Kriechbaum  SD, Wiedenroth  CB, Hesse  ML, Ajnwojner  R, Keller  T, Sebastian Wolter  J, et al.  Development of renal function during staged balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Scand J Clin Lab Invest  2019;79:268–275. 10.1080/00365513.2019.1601765 PubMed DOI

Andreassen  AK, Ragnarsson  A, Gude  E, Geiran  O, Andersen  R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart  2013;99:1415–1420. 10.1136/heartjnl-2012-303549 PubMed DOI

Kurzyna  M, Darocha  S, Pietura  R, Pietrasik  A, Norwa  J, Mańczak  R, et al.  Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience. Kardiol Pol  2017;75:645–654. 10.5603/KP.a2017.0091 PubMed DOI

Olsson  KM, Wiedenroth  CB, Kamp  JC, Breithecker  A, Fuge  J, Krombach  GA, et al.  Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir J  2017;49:1602409. 10.1183/13993003.02409-2016 PubMed DOI

Jansa  P, Heller  S, Svoboda  M, Pad'our  M, Ambrož  D, Dytrych  V, et al.  Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: impact on clinical and hemodynamic parameters, quality of life and risk profile. J Clin Med  2020;9:3608. 10.3390/jcm9113608 PubMed DOI PMC

Godinas  L, Bonne  L, Budts  W, Belge  C, Leys  M, Delcroix  M, et al.  Balloon pulmonary angioplasty for the treatment of nonoperable chronic thromboembolic pulmonary hypertension: single-center experience with low initial complication rate. J Vasc Interv Radiol  2019;30:1265–1272. 10.1016/j.jvir.2019.03.023 PubMed DOI

Anand  V, Frantz  RP, DuBrock  H, Kane  GC, Krowka  M, Yanagisawa  R, et al.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: initial single-center experience. Mayo Clin Proc Innov Qual Outcomes  2019;3:311–318. 10.1016/j.mayocpiqo.2019.06.006 PubMed DOI PMC

Wiedenroth  CB, Rolf  A, Steinhaus  K, Adameit  MSD, Kriechbaum  SD, Haas  M, et al.  Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant  2023;42:134–139. 10.1016/j.healun.2022.08.011 PubMed DOI

Hoole  SP, Coghlan  JG, Cannon  JE, Taboada  D, Toshner  M, Sheares  K, et al.  Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience. Open Heart  2020;7:e001144. 10.1136/openhrt-2019-001144 PubMed DOI PMC

van Thor  MCJ, Lely  RJ, Braams  NJ, Ten Klooster  L, Beijk  MAM, Heijmen  RH, et al.  Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in The Netherlands. Neth Heart J  2020;28:81–88. 10.1007/s12471-019-01352-6 PubMed DOI PMC

Darocha  S, Roik  M, Kopeć  G, Araszkiewicz  A, Furdal  M, Lewandowski  M, et al.  Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry. EuroIntervention  2022;17:1104–1111. 10.4244/EIJ-D-21-00230 PubMed DOI PMC

Karyofyllis  P, Demerouti  E, Giannakoulas  G, Anthi  A, Arvanitaki  A, Athanassopoulos  G, et al.  Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension in Greece: data from the Hellenic Pulmonary Hypertension Registry. J Clin Med  2022;11:2211. 10.3390/jcm11082211 PubMed DOI PMC

Piliero  N, Thony  F, Guillien  A, Rousseau  J, Finas  M, Vautrin  E, et al.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: evaluation of haemodynamic effects, complication rates and radiation exposure over time. Arch Cardiovasc Dis  2022;115:295–304. 10.1016/j.acvd.2022.02.010 PubMed DOI

Ogawa  A, Satoh  T, Fukuda  T, Sugimura  K, Fukumoto  Y, Emoto  N, et al.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a multicenter registry. Circ Cardiovasc Qual Outcomes  2017;10:e004029. 10.1161/CIRCOUTCOMES.117.004029 PubMed DOI

Chausheva  S, Naito  A, Ogawa  A, Seidl  V, Winter  MP, Sharma  S, et al.  Chronic thromboembolic pulmonary hypertension in Austria and Japan. J Thorac Cardiovasc Surg  2019;158:604–614.e2. 10.1016/j.jtcvs.2019.01.019 PubMed DOI

Hug  KP, Gerry Coghlan  J, Cannon  J, Taboada  D, Toshner  M, Sheares  K, et al.  Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment. J Heart Lung Transplant  2021;40:1223–1234. 10.1016/j.healun.2021.06.011 PubMed DOI

Darocha  S, Pietura  R, Pietrasik  A, Norwa  J, Dobosiewicz  A, Pilka  M, et al.  Improvement in quality of life and hemodynamics in chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty. Circ J  2017;81:552–557. 10.1253/circj.CJ-16-1075 PubMed DOI

Sakamoto  H, Goda  A, Tobita  K, Takeuchi  K, Kikuchi  H, Inami  T, et al.  EmPHasis-10 health-related quality of life and exercise capacity in chronic thromboembolic pulmonary hypertension after balloon angioplasty. J Am Heart Assoc  2022;11:e026400. 10.1161/JAHA.122.026400 PubMed DOI PMC

Aoki  T, Sugimura  K, Terui  Y, Tatebe  S, Fukui  S, Miura  M, et al.  Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty—a randomized controlled study. Int J Cardiol Heart Vasc  2020;29:100579. 10.1016/j.ijcha.2020.100579 PubMed DOI PMC

Wiedenroth  CB, Rieth  AJ, Kriechbaum  S, Ghofrani  HA, Breithecker  A, Haas  M, et al.  Exercise right heart catheterization before and after balloon pulmonary angioplasty in inoperable patients with chronic thromboembolic pulmonary hypertension. Pulm Circ  2020;10:2045894020917884. 10.1177/2045894020917884 PubMed DOI PMC

Kanar  BG, Mutlu  B, Atas  H, Akaslan  D, Yıldızeli  B. Improvements of right ventricular function and hemodynamics after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Echocardiography  2019;36:2050–2056. 10.1111/echo.14503 PubMed DOI

Li  W, Yang  T, Quan  RL, Chen  XX, An  J, Zhao  ZH, et al.  Balloon pulmonary angioplasty reverse right ventricular remodelling and dysfunction in patients with inoperable chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. Eur Radiol  2021;31:3898–3908. 10.1007/s00330-020-07481-6 PubMed DOI

Yamasaki  Y, Abe  K, Kamitani  T, Hosokawa  K, Kawakubo  M, Sagiyama  K, et al.  Balloon pulmonary angioplasty improves right atrial reservoir and conduit functions in chronic thromboembolic pulmonary hypertension. Eur Heart J Cardiovasc Imaging  2020;21:855–862. 10.1093/ehjci/jeaa064 PubMed DOI

Roller  FC, Schüssler  A, Hasse  A, Kriechbaum  S, Richter  M, Guth  S, et al.  Effects of BPA on right ventricular mechanical dysfunction in patients with inoperable CTEPH—a cardiac magnetic resonance study. Eur J Radiol  2022;147:110111. 10.1016/j.ejrad.2021.110111 PubMed DOI

Piłka  M, Darocha  S, Banaszkiewicz  M, Florczyk  M, Wieteska  M, Dobosiewicz  A, et al.  The evolution of electrocardiographic signs of right ventricular overload after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Pol Arch Intern Med  2019;129:451–459. 10.20452/pamw.14877 PubMed DOI

Magoń  W, Stępniewski  J, Waligóra  M, Jonas  K, Podolec  P, Kopeć  G. Pulmonary artery elastic properties after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Can J Cardiol  2019;35:422–429. 10.1016/j.cjca.2019.01.016 PubMed DOI

Nagai  T, Ikeda  N, Iijima  R, Hara  H, Nakamura  M. Impact and safety of balloon pulmonary angioplasty for elderly patients. Pulm Circ  2022;12:e12009. 10.1002/pul2.12009 PubMed DOI PMC

Nishiyama  M, Inoue  Y, Sasaki  H, Seike  Y, Aoki  T, Ueda  J, et al.  Long-term outcomes of combined pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Gen Thorac Cardiovasc Surg  2023;71:91–298. 10.1007/s11748-022-01872-w PubMed DOI

Wiedenroth  CB, Olsson  KM, Guth  S, Breithecker  A, Haas  M, Kamp  JC, et al.  Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease. Pulm Circ  2018;8:2045893217753122. 10.1177/2045893217753122 PubMed DOI PMC

Pengo  V, Denas  G, Zoppellaro  G, Jose  SP, Hoxha  A, Ruffatti  A, et al.  Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood  2018;132:1365–1371. 10.1182/blood-2018-04-848333 PubMed DOI

Cottin  V, Bensimon  L, Raguideau  F, Chaize  G, Hakmé  A, Levy-Bachelot  L, et al.  Hospital costs of balloon pulmonary angioplasty (BPA) procedure and management for CTEPH patients: an observational study based on the French national hospital discharge database (PMSI). PLoS One  2021;16:e0260483. 10.1371/journal.pone.0260483 PubMed DOI PMC